These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 6129857)
1. Pharmacological studies with quazepam, a new benzodiazepine hypnotic. Ongini E; Parravicini L; Bamonte F; Guzzon V; Iorio LC; Barnett A Arzneimittelforschung; 1982; 32(11):1456-62. PubMed ID: 6129857 [TBL] [Abstract][Full Text] [Related]
2. The sedative-hypnotic properties of quazepam, a new hypnotic agent. Barnett A; Iorio LC; Ongini E Arzneimittelforschung; 1982; 32(11):1452-6. PubMed ID: 6129856 [TBL] [Abstract][Full Text] [Related]
3. [Electroencephalographic study of Sch 161 (quazepam), a new benzodiazepine hypnotic, in rats and rabbits]. Kawasaki H; Urabe M; Nuki C; Yamamoto R; Takasaki K; Ohno H Nihon Yakurigaku Zasshi; 1987 Oct; 90(4):221-38. PubMed ID: 3428780 [TBL] [Abstract][Full Text] [Related]
4. Differential effects of benzodiazepines on EEG activity and hypnogenic mechanisms of the brain stem in cats. Mariotti M; Ongini E Arch Int Pharmacodyn Ther; 1983 Aug; 264(2):203-19. PubMed ID: 6139096 [TBL] [Abstract][Full Text] [Related]
5. Preclinical safety evaluation of the benzodiazepine quazepam. Black HE; Szot RJ; Arthaud LE; Massa T; Mylecraine L; Klein M; Lake R; Fabry A; Kaminska GZ; Sinha DP Arzneimittelforschung; 1987 Aug; 37(8):906-13. PubMed ID: 2890357 [TBL] [Abstract][Full Text] [Related]
6. Sedative-hypnotic properties of a new benzodiazepine in comparison with flurazepam. Pharmacological and clinical findings. Babbini M; Torrielli MV; Strumia E; Gaiardi M; Bartoletti M; De Marchi F Arzneimittelforschung; 1975 Aug; 25(8):1294-1300. PubMed ID: 241364 [TBL] [Abstract][Full Text] [Related]
7. Effects of a new benzodiazepine hypnotic (quazepam--SCH 16134) on EEG synchronization and sleep-inducing mechanisms in cats. Ongini E; Mariotti M; Mancia M Neuropharmacology; 1982 May; 21(5):405-12. PubMed ID: 7110529 [TBL] [Abstract][Full Text] [Related]
8. The acute effect of quazepam on the sleep of chronic insomniacs. A dose-response study. Tietz EI; Roth T; Zorick FJ; Piccione P; Kramer M Arzneimittelforschung; 1981; 31(11):1963-6. PubMed ID: 6119098 [TBL] [Abstract][Full Text] [Related]
9. Pharmacology of midazolam. Pieri L; Schaffner R; Scherschlicht R; Polc P; Sepinwall J; Davidson A; Möhler H; Cumin R; Da Prada M; Burkard WP; Keller HH; Müller RK; Gerold M; Pieri M; Cook L; Haefely W Arzneimittelforschung; 1981; 31(12a):2180-201. PubMed ID: 6120698 [TBL] [Abstract][Full Text] [Related]
10. The disposition and metabolism of a hypnotic benzodiazepine, quazepam, in the hamster and mouse. Hilbert J; Pramanik B; Symchowicz S; Zampaglione N Drug Metab Dispos; 1984; 12(4):452-9. PubMed ID: 6148212 [TBL] [Abstract][Full Text] [Related]
11. Pharmacology of 2-o-chlororbenzoyl-4-chloro-N-methyl-N alpha-glycylglycinanilide hydrate (45-0088-S), a compound with benzodiazepine-like properties. Hirose K; Matsushita A; Eigyo M; Jyoyama H; Fujita A; Tsukinoki Y; Shiomi T; Matsubara K Arzneimittelforschung; 1981; 31(1):63-9. PubMed ID: 6111327 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological studies on timiperone, a new neuroleptic drug Part II: General pharmacological properties. Yamasaki T; Kojima H; Tanaka M; Aibara S; Hirohashi M; Kasai Y; Tsubokawa M; Watanabe K; Akashi A Arzneimittelforschung; 1981; 31(4):707-15. PubMed ID: 6113834 [TBL] [Abstract][Full Text] [Related]
13. General pharmacological properties of UFT, a new type of anti-cancer agent consisting of 1-(2-tetrahydrofuryl)-5-fluorouracil (FT) and uracil. I: Pharmacological analysis of the combined effect of FT and uracil. Yamamoto J; Toide K; Haruno A; Yoshimura Y; Unemi N Arzneimittelforschung; 1981; 31(8):1268-78. PubMed ID: 6794578 [TBL] [Abstract][Full Text] [Related]
14. [Psycopharmacological and general pharmacological studies of 7-chloro-1-cyclopropylmethyl-1, 3-dihydro-5-(2-fluorophenyl)-2H-1, 4-benzodiazepin-2-one (KB-509) (author's transl)]. Sukamoto T; Aikawa K; Itoh K; Nose T Nihon Yakurigaku Zasshi; 1980 Sep; 76(6):447-68. PubMed ID: 7203280 [TBL] [Abstract][Full Text] [Related]
15. Quazepam and flurazepam: differential pharmacokinetic and pharmacodynamic characteristics. Hilbert JM; Battista D J Clin Psychiatry; 1991 Sep; 52 Suppl():21-6. PubMed ID: 1680120 [TBL] [Abstract][Full Text] [Related]
16. Neuropharmacology of a new psychotropic 2,3-benzodiazepine. Andrási F; Horváth K; Sineger E; Berzsenyi P; Borsy J; Kenessey A; Tarr M; Láng T; Kórösi J; Hámori T Arzneimittelforschung; 1987 Oct; 37(10):1119-24. PubMed ID: 2893623 [TBL] [Abstract][Full Text] [Related]
17. Sch 50971, an orally active histamine H3 receptor agonist, inhibits central neurogenic vascular inflammation and produces sedation in the guinea pig. McLeod RL; Aslanian R; del Prado M; Duffy R; Egan RW; Kreutner W; McQuade R; Hey JA J Pharmacol Exp Ther; 1998 Oct; 287(1):43-50. PubMed ID: 9765320 [TBL] [Abstract][Full Text] [Related]
18. The pharmacological profile of a potential hypnotic compound RU 31158. Johns TG; Piper DC; James GW Arch Int Pharmacodyn Ther; 1979 Jul; 240(1):53-65. PubMed ID: 41495 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological properties of 6-(o-chlorophenyl)-8-ethyl-1-methyl-4H-s-triazolo[3,4-c]thieno[2,3-e] [1,4]diazepine (Y-7131), a new anti-anxiety drug. Tsumagari T; Nakajima A; Fukuda T; Shuto S; Kenjo T; Morimoto Y; Takigawa Y Arzneimittelforschung; 1978; 28(7):1158-64. PubMed ID: 39570 [TBL] [Abstract][Full Text] [Related]
20. A new psychoactive 5H-2,3-benzodiazepine with a unique spectrum of activity. Horváth K; Andrási F; Berzsenyi P; Pátfalusi M; Patthy M; Szabó G; Sebestyén L; Bagdy E; Körösi J; Botka P Arzneimittelforschung; 1989 Aug; 39(8):894-9. PubMed ID: 2573361 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]